Andrés Kychenthal
About
In The Last Decade
Andrés Kychenthal
17 papers receiving 641 citations
Peers
Comparison fields: 5 of 44
- Radiology, Nuclear Medicine and Imaging 529
- Ophthalmology 505
- Pulmonary and Respiratory Medicine 140
- Pediatrics, Perinatology and Child Health 124
- Molecular Biology 86
Countries citing papers authored by Andrés Kychenthal
This map shows the geographic impact of Andrés Kychenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrés Kychenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrés Kychenthal more than expected).
Fields of papers citing papers by Andrés Kychenthal
This network shows the impact of papers produced by Andrés Kychenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrés Kychenthal. The network helps show where Andrés Kychenthal may publish in the future.
Co-authorship network of co-authors of Andrés Kychenthal
This figure shows the co-authorship network connecting the top 25 collaborators of Andrés Kychenthal. A scholar is included among the top collaborators of Andrés Kychenthal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrés Kychenthal. Andrés Kychenthal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 3 | |
| 3 | Ocular and Systemic Adverse Events Asociated with Intravitreal Bevacizumab in the Treatment of Retinopathy of Prematurity | 0 |
| 4 | Systemic And Ocular Adverse Events After 334 Injections Of Intravitreal Bevacizumab In The Treatment Of ROP: Five-Year Follow-Up In 3 Centers | 0 |
| 5 | 61 | |
| 6 | 31 | |
| 7 | 65 | |
| 8 | 202 | |
| 9 | 23 | |
| 10 | 79 | |
| 11 | 8 | |
| 12 | 86 | |
| 13 | 4 | |
| 14 | 0 | |
| 15 | 15 | |
| 16 | 44 | |
| 17 | 10 | |
| 18 | Syncope: etiology, prognosis, and relationship to age | 28 |
| 19 | [Syncope: recurrence and prognosis during 2 years]. | 1 |
| 20 | Tubular markers in renal transplant patients under cyclosporine. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.